We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Kinase-independent role of mTOR and on-/off-target effects of an mTOR kinase inhibitor

    mTOR, as a serine/threonine kinase, is a widely pursued anticancer target. Multiple clinical trials of mTOR kinase inhibitors are ongoing, but their...

    Cuiqing Fan, Mark Wunderlich, ... Yi Zheng in Leukemia
    Article 02 August 2023
  2. Mechanism of anticancer effect of ETP-45658, a PI3K/AKT/mTOR pathway inhibitor on HT-29 Cells

    The PI3K pathway plays a crucial role in tumor cell proliferation across various cancers, including colon cancer, making it a promising treatment...

    Fatih Yulak, Ahmet Kemal Filiz, ... Mustafa Ergul in Medical Oncology
    Article 27 October 2023
  3. Retrospective Assessment of Translational Pharmacokinetic–Pharmacodynamic Modeling Performance: A Case Study with Apitolisib, a Dual PI3K/mTOR Inhibitor

    Background and Objectives

    Despite significant progress in biomedical research, the rate of success in oncology drug development remains inferior to...

    Anita Moein, ** Y. **, ... Harvey Wong in Drugs in R&D
    Article Open access 03 May 2024
  4. PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor

    Purpose

    Medulloblastoma (MB), a common and heterogeneous posterior fossa tumor in pediatric patients, presents diverse prognostic outcomes. To advance...

    Shizun Wang, Dan Zhang, ... Yuqin Liu in Journal of Neuro-Oncology
    Article 25 April 2024
  5. P4HA2 activates mTOR via hydroxylation and targeting P4HA2-mTOR inhibits lung adenocarcinoma cell growth

    Mammalian target of rapamycin (mTOR) kinase functions as a central regulator of cell growth and metabolism, and its complexes mTORC1 and mTORC2...

    Ersuo **, Shengjie Wang, ... Hong-Tao Zhang in Oncogene
    Article Open access 23 April 2024
  6. Potential of semen coicis in enhancing the anti-tumor effects of PD-1 inhibitor on A549 cell lines by blocking the PI3K-AKT-mTOR pathway

    Background

    The objective of this research was to investigate how the combination of semen coicis extract and PD-1 inhibitors can potentially work...

    Zi-Yi Fu, Ying Huang, ... **ao-Hong Liu in Clinical and Translational Oncology
    Article 30 March 2024
  7. Duck Tembusu virus induces incomplete autophagy via the ERK/mTOR and AMPK/mTOR signalling pathways to promote viral replication in neuronal cells

    Duck Tembusu virus (DTMUV) is a neurotropic virus in the genus Flavivirus that causes massive economic losses to the poultry industry in China and...

    Qing Wang, Yaqian Jiang, ... Guijun Wang in Veterinary Research
    Article Open access 07 November 2023
  8. Calcineurin and mTOR inhibitors in kidney transplantation: integrative metamodeling on transplant survival and kidney function

    In our study, we examined the efficacy of mTOR (mammalian target of rapamycin) inhibitors, specifically rapamycin (Rap), compared to calcineurin...

    Hina Khalid, Muhammad Mazhar Fareed, ... Sergey Shityakov in International Urology and Nephrology
    Article 26 September 2023
  9. YAP inhibition overcomes adaptive resistance in HER2-positive gastric cancer treated with trastuzumab via the AKT/mTOR and ERK/mTOR axis

    Background

    Human epidermal growth factor receptor 2 (HER2)-positive gastric cancer (GC) is a heterogeneous GC subtype characterized by the...

    Jiao Qiao, Mei Feng, ... Liyan Cui in Gastric Cancer
    Article Open access 23 May 2024
  10. Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing/refractory multi-lineage autoimmune cytopenia

    Data on mTOR inhibitors (mTORi) in autoimmune cytopenia (AIC), in adults are scarce. We retrospectively analysed 30 cases of refractory or relapsing...

    Boris Sorin, Jehane Fadlallah, ... Lionel Galicier in Annals of Hematology
    Article 29 June 2023
  11. mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy

    In the spectrum of oncocytic renal neoplasms, a subset of tumors with high-grade-appearing histologic features harboring pathogenic mutations in...

    Anna Caliò, Stefano Marletta, ... Guido Martignoni in Virchows Archiv
    Article Open access 08 November 2023
  12. Disparities in PI3K/mTOR inhibitor use, toxicities, and outcomes among patients with metastatic breast cancer

    Purpose

    Novel agents such as PI3K and mTOR inhibitors (PI3K/mTORi) have expanded treatment options in metastatic breast cancer (MBC). Nevertheless,...

    Claire Sathe, Melissa K. Accordino, ... Dawn L. Hershman in Breast Cancer Research and Treatment
    Article 04 May 2024
  13. OTUD7B knockdown inhibits proliferation and autophagy through AKT/mTOR signaling pathway in human prostate cancer cell

    Prostate cancer (PCa) is the second leading disease of cancer-related death in men around the world, and it is almost impossible to treat advanced...

    Yae Ji Kim, Hui Ju Lee, ... Ju Young Jung in Discover Oncology
    Article Open access 27 June 2024
  14. Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age

    Introduction

    Mechanistic target of rapamycin (mTOR) inhibitors sirolimus and everolimus are an effective therapy for subependymal giant cell...

    Dominika Śmiałek, Katarzyna Kotulska, ... Sergiusz Jóźwiak in Neurology and Therapy
    Article Open access 21 April 2023
  15. Lysophosphatidic acid is associated with oocyte maturation by enhancing autophagy via PI3K-AKT-mTOR signaling pathway in granulosa cells

    Background

    Folliculogenesis is a complex network of interacting cellular signals between somatic cells and oocytes. Many components in ovarian...

    Jia Liu, Chong Wang in Journal of Ovarian Research
    Article Open access 11 July 2023
  16. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease

    The mammalian target of rapamycin (mTOR) is a protein kinase that controls cellular metabolism, catabolism, immune responses, autophagy, survival,...

    Vivek Panwar, Aishwarya Singh, ... Manoj Garg in Signal Transduction and Targeted Therapy
    Article Open access 02 October 2023
  17. Neuroprotective Effect of Chrysophanol as a PI3K/AKT/mTOR Signaling Inhibitor in an Experimental Model of Autologous Blood-induced Intracerebral Hemorrhage

    Objective

    Intracerebral hemorrhage (ICH) refers to predominant, sporadic, and non-traumatic bleeding in the brain parenchyma. The PI3K/AKT/mTOR...

    Kuldeep Singh Jadaun, Sidharth Mehan, ... Naif Alsuhaymi in Current Medical Science
    Article 26 January 2022
  18. Orf virus induces complete autophagy to promote viral replication via inhibition of AKT/mTOR and activation of the ERK1/2/mTOR signalling pathway in OFTu cells

    Orf virus (ORFV) is the causative agent of contagious ecthyma, which is an important zoonotic pathogen with a widespread distribution affecting...

    Lijun Lv, Jiyu Guan, ... Kui Zhao in Veterinary Research
    Article Open access 14 March 2023
  19. Inhibitory Effect of PPARδ Agonist GW501516 on Proliferation of Hypoxia-induced Pulmonary Arterial Smooth Muscle Cells by Regulating the mTOR Pathway

    Objective

    This study aimed to investigate the effects of the peroxisome proliferator-activated receptor δ (PPARδ) agonist GW501516 on the...

    Chang-gui Chen, Chun-feng Yi, ... Li-qun He in Current Medical Science
    Article 22 August 2023
Did you find what you were looking for? Share feedback.